| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 40.608.341 $ | 97,30 | 2.023.044 | |||||||
| Apellis Pharmaceuticals Inc | Apellis Pharmaceuticals, Inc. | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 746.146 $ | 1,79 | 18.547 | |
| Alkermes PLC | Alkermes plc | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 590.229 $ | 1,41 | 16.692 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 562.207 $ | 1,35 | 1.074 | |
| TG Therapeutics Inc | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 548.994 $ | 1,32 | 16.526 | |
| Insmed Inc | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 543.704 $ | 1,30 | 3.325 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corporation | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 527.733 $ | 1,26 | 10.735 | |
| Apogee Therapeutics Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 522.443 $ | 1,25 | 6.207 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 506.447 $ | 1,21 | 4.805 | |
| Summit Therapeutics Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 504.810 $ | 1,21 | 26.625 | |
| United Therapeutics Corporation | United Therapeutics Corporation | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 504.626 $ | 1,21 | 851 | |
| Praxis Precision Medicines Inc | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 502.939 $ | 1,21 | 1.561 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 500.221 $ | 1,20 | 7.978 | |
| Cogent Biosciences Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 494.520 $ | 1,18 | 12.848 | |
| Bridgebio Pharma Inc | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 482.170 $ | 1,16 | 6.493 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 480.930 $ | 1,15 | 7.059 | |
| Cytokinetics Inc | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 480.154 $ | 1,15 | 7.285 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 478.769 $ | 1,15 | 1.447 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 476.208 $ | 1,14 | 11.103 | |
| Nuvalent Inc | Nuvalent, Inc. | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 474.651 $ | 1,14 | 4.633 | |
| Kymera Therapeutics Inc | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 473.587 $ | 1,13 | 5.686 | |
| CG Oncology Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 472.812 $ | 1,13 | 6.986 | |
| Natera Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 471.576 $ | 1,13 | 2.358 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 471.366 $ | 1,13 | 3.578 | |
| Twist Bioscience Corporation | Twist Bioscience Corporation | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 470.068 $ | 1,13 | 9.892 | |
| Krystal Biotech Inc | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 469.626 $ | 1,13 | 1.818 | |
| Vaxcyte Inc | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 468.192 $ | 1,12 | 8.057 | |
| Mirum Pharmaceuticals Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 466.704 $ | 1,12 | 5.052 | |
| Amicus Therapeutics Inc. | Amicus Therapeutics, Inc. | EC | 03152W109 | Long | Börsenkurs (Stufe 1) | 466.451 $ | 1,12 | 32.258 | |
| Travere Therapeutics Inc | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 465.437 $ | 1,12 | 15.666 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 465.408 $ | 1,12 | 6.198 | |
| Arcellx Inc | Arcellx, Inc. | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 465.365 $ | 1,12 | 4.053 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 462.039 $ | 1,11 | 598 | |
| Incyte Corporation. | Incyte Corporation | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 460.906 $ | 1,10 | 4.897 | |
| Celcuity Inc. | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 457.017 $ | 1,09 | 4.004 | |
| Revolution Medicines Inc | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 452.602 $ | 1,08 | 4.654 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 450.665 $ | 1,08 | 6.973 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 447.809 $ | 1,07 | 5.149 | |
| Biogen Inc | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 446.225 $ | 1,07 | 2.434 | |
| Arcutis Biotherapeutics Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 443.140 $ | 1,06 | 18.809 | |
| AbbVie Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 442.810 $ | 1,06 | 2.036 | |
| Gilead Sciences Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 442.500 $ | 1,06 | 3.175 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics A.G. | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 441.640 $ | 1,06 | 9.284 | |
| Biomarin Pharmaceutical Inc. | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 434.126 $ | 1,04 | 7.685 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 434.087 $ | 1,04 | 15.671 | |
| Amgen Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 431.720 $ | 1,03 | 1.227 | |
| ImmunityBio Inc | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 429.911 $ | 1,03 | 56.051 | |
| Beam Therapeutics Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 423.554 $ | 1,01 | 17.774 | |
| Viking Therapeutics Inc. | Viking Therapeutics, Inc. | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 421.816 $ | 1,01 | 12.963 | |
| Vera Therapeutics Inc. | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 420.846 $ | 1,01 | 10.461 | |
| Moderna Inc | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 420.726 $ | 1,01 | 8.282 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 420.194 $ | 1,01 | 941 | |
| Erasca Inc | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 418.965 $ | 1,00 | 25.894 | |
| Acadia Pharmaceuticals Inc | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 415.616 $ | 1,00 | 18.671 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 363.849 $ | 0,87 | 16.721 | |
| Agios Pharmaceuticals Inc | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 357.211 $ | 0,86 | 10.559 | |
| Ultragenyx Pharmaceuticals Inc | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 356.171 $ | 0,85 | 17.001 | |
| Disc Medicine Inc | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 353.972 $ | 0,85 | 5.536 | |
| Immunome Inc | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 351.123 $ | 0,84 | 16.055 | |
| Immunovant Inc | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 348.754 $ | 0,84 | 14.040 | |
| BioCryst Pharmaceuticals Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 346.595 $ | 0,83 | 36.407 | |
| Veracyte Inc | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 344.969 $ | 0,83 | 10.710 | |
| Dyne Therapeutics Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 340.917 $ | 0,82 | 18.804 | |
| Catalyst Pharmaceuticals Inc. | Catalyst Pharmaceuticals, Inc. | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 307.222 $ | 0,74 | 12.408 | |
| Syndax Pharmaceuticals Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 299.428 $ | 0,72 | 12.818 | |
| Denali Therapeutics Inc | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 297.331 $ | 0,71 | 15.486 | |
| IDEAYA Biosciences Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 296.848 $ | 0,71 | 8.909 | |
| Spyre Therapeutics Inc | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 295.074 $ | 0,71 | 5.850 | |
| GRAIL Inc | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 294.369 $ | 0,71 | 5.696 | |
| Viridian Therapeutics Inc | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 285.400 $ | 0,68 | 14.591 | |
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals, Inc. | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 280.985 $ | 0,67 | 91.526 | |
| Kodiak Sciences Inc | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 280.106 $ | 0,67 | 7.348 | |
| Soleno Therapeutics Inc | Soleno Therapeutics, Inc. | EC | 834203309 | Long | Börsenkurs (Stufe 1) | 273.967 $ | 0,66 | 8.183 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 269.299 $ | 0,65 | 3.209 | |
| Intellia Therapeutics Inc | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 263.182 $ | 0,63 | 20.529 | |
| Mineralys Therapeutics Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 262.692 $ | 0,63 | 9.697 | |
| Arcus Biosciences Inc. | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 255.571 $ | 0,61 | 11.832 | |
| Ardelyx Inc | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 251.071 $ | 0,60 | 41.915 | |
| Adma Biologics Inc | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 242.324 $ | 0,58 | 26.895 | |
| Nurix Therapeutics Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 238.173 $ | 0,57 | 15.366 | |
| Tango Therapeutics Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 225.664 $ | 0,54 | 10.787 | |
| Celldex Therapeutics Inc. | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 212.048 $ | 0,51 | 6.685 | |
| Novavax Inc | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 207.806 $ | 0,50 | 25.529 | |
| Oruka Therapeutics Inc | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 204.097 $ | 0,49 | 4.161 | |
| Olema Pharmaceuticals Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 201.524 $ | 0,48 | 13.516 | |
| Stoke Therapeutics Inc | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 200.439 $ | 0,48 | 6.156 | |
| Vericel Corporation | Vericel Corporation | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 196.366 $ | 0,47 | 6.104 | |
| Capricor Therapeutics Inc | Capricor Therapeutics, Inc. | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 194.803 $ | 0,47 | 6.408 | |
| Palvella Therapeutics Inc. | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 186.850 $ | 0,45 | 1.499 | |
| Biohaven Ltd | Biohaven Ltd. | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 177.838 $ | 0,43 | 21.021 | |
| Monte Rosa Therapeutics Inc | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 176.870 $ | 0,42 | 10.752 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 169.313 $ | 0,41 | 11.573 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 156.191 $ | 0,37 | 44.499 | |
| AnaptysBio Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 155.288 $ | 0,37 | 2.800 | |
| Relay Therapeutics Inc | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 154.016 $ | 0,37 | 15.479 | |
| Uniqure N.V. | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 151.695 $ | 0,36 | 9.278 | |
| ORIC Pharmaceuticals Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 150.368 $ | 0,36 | 11.868 | |
| Mannkind Corporation | MannKind Corporation | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 146.422 $ | 0,35 | 59.764 | |
| Caredx Inc | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 140.460 $ | 0,34 | 8.091 | |
| Taysha Gene Therapies Inc. | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 137.770 $ | 0,33 | 30.821 | |
| Tyra Biosciences Inc | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 137.191 $ | 0,33 | 3.582 | |
| Geron Corp. | Geron Corporation | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 135.302 $ | 0,32 | 90.807 | |
| Day One Biopharmaceuticals Inc. | Day One Biopharmaceuticals, Inc. | EC | 23954D109 | Long | Börsenkurs (Stufe 1) | 130.462 $ | 0,31 | 6.085 | |
| Precigen Inc | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 126.955 $ | 0,30 | 32.805 | |
| VIR Biotechnology Inc | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 123.773 $ | 0,30 | 13.814 | |
| KalVista Pharmaceuticals Inc. | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 118.525 $ | 0,28 | 5.888 | |
| Cytomx Therapeutics Inc | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 115.841 $ | 0,28 | 24.647 | |
| Annexon Inc | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 115.731 $ | 0,28 | 20.890 | |
| Kura Oncology Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 112.088 $ | 0,27 | 13.787 | |
| Inhibrx Biosciences Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 108.913 $ | 0,26 | 1.620 | |
| Sellas Life Sciences Group Inc | SELLAS Life Sciences Group, Inc. | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 108.432 $ | 0,26 | 25.634 | |
| Janux Therapeutics Inc | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 108.184 $ | 0,26 | 7.783 | |
| Compass Therapeutics Inc | Compass Therapeutics, Inc. | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 106.482 $ | 0,26 | 20.129 | |
| Savara Inc | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 106.028 $ | 0,25 | 19.419 | |
| Rigel Pharmaceuticals Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 104.699 $ | 0,25 | 3.872 | |
| Sana Biotechnology Inc | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 104.653 $ | 0,25 | 36.338 | |
| Cullinan Therapeutics Inc | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 101.474 $ | 0,24 | 7.141 | |
| ARS Pharmaceuticals Inc | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 97.075 $ | 0,23 | 12.089 | |
| Zenas BioPharma Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 96.773 $ | 0,23 | 4.950 | |
| Xencor Inc | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 93.670 $ | 0,22 | 7.767 | |
| Replimune Group Inc | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 93.146 $ | 0,22 | 12.176 | |
| Vor Biopharma Inc. | Vor BioPharma, Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 92.607 $ | 0,22 | 5.191 | |
| Sionna Therapeutics Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 91.205 $ | 0,22 | 2.275 | |
| ArriVent BioPharma Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 88.312 $ | 0,21 | 3.828 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc. | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 78.140 $ | 0,19 | 22.262 | |
| Bicara Therapeutics Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 77.690 $ | 0,19 | 3.906 | |
| Prime Medicine Inc | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 77.099 $ | 0,18 | 22.155 | |
| Absci Corp. | Absci Corporation | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 74.289 $ | 0,18 | 24.763 | |
| Altimmune Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 73.205 $ | 0,18 | 23.768 | |
| Emergent Biosolutions Inc | Emergent BioSolutions, Inc. | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 72.675 $ | 0,17 | 8.756 | |
| Allogene Therapeutics Inc | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 70.801 $ | 0,17 | 29.017 | |
| Hyperliquid Strategies Inc. | Hyperliquid Strategies, Inc. | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 69.458 $ | 0,17 | 13.646 | |
| 4D Molecular Therapeutics Inc | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 68.307 $ | 0,16 | 7.337 | |
| Vanda Pharmace Inc | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 65.548 $ | 0,16 | 9.486 | |
| Regenxbio Inc. | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 63.621 $ | 0,15 | 7.592 | |
| Lexeo Therapeutics Inc | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 59.518 $ | 0,14 | 10.369 | |
| Verastem Inc | Verastem, Inc. | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 59.434 $ | 0,14 | 11.214 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corporation | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 56.817 $ | 0,14 | 12.626 | |
| Myriad Genetics Inc. | Myriad Genetics, Inc. | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 54.113 $ | 0,13 | 12.025 | |
| Prothena Corporation PLC | Prothena Corp plc | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 53.207 $ | 0,13 | 5.474 | |
| Ocugen Inc. | Ocugen Inc | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 52.624 $ | 0,13 | 29.074 | |
| Rocket Pharmaceuticals Inc | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 51.953 $ | 0,12 | 14.512 | |
| MiMedx Group Inc. | MiMedx Group, Inc. | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 50.193 $ | 0,12 | 12.707 | |
| Akebia Therapeutics Inc. | Akebia Therapeutics, Inc. | EC | 00972D105 | Long | Börsenkurs (Stufe 1) | 46.728 $ | 0,11 | 33.617 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corporation | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 45.353 $ | 0,11 | 14.773 | |
| Invivyd Inc | Invivyd, Inc. | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 40.920 $ | 0,10 | 31.477 | |
| Perspective Therapeutics Inc | Perspective Therapeutics, Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 39.773 $ | 0,10 | 9.538 | |
| Damora Therapeutics Inc. | Damora Therapeutics, Inc. | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 13.520 $ | 0,03 | 522 | |
| 40.608.341 $ | 97,30 | 2.023.044 |